| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |